<!doctype html>
<!--
  Minimal Mistakes Jekyll Theme 4.24.0 by Michael Rose
  Copyright 2013-2020 Michael Rose - mademistakes.com | @mmistakes
  Free for personal and commercial use under the MIT license
  https://github.com/mmistakes/minimal-mistakes/blob/master/LICENSE
-->
<html lang="en" class="no-js">
  <head>
    <meta charset="utf-8">

<!-- begin _includes/seo.html --><title>Inventory of clinical studies in renal MRI - Minimal Mistakes</title>
<meta name="description" content="An inventory of clinical studies involving renal MRI, either ongoing or closed.">


  <meta name="author" content="Serhii">
  
  <meta property="article:author" content="Serhii">
  


<meta property="og:type" content="article">
<meta property="og:locale" content="en_US">
<meta property="og:site_name" content="Minimal Mistakes">
<meta property="og:title" content="Inventory of clinical studies in renal MRI">
<meta property="og:url" content="http://localhost:4000/resources/inventory%20of%20clinical%20studies%20in%20renal%20mri/">


  <meta property="og:description" content="An inventory of clinical studies involving renal MRI, either ongoing or closed.">



  <meta property="og:image" content="http://localhost:4000/assets/images/bio-photo.jpg">



  <meta name="twitter:site" content="@mmistakes">
  <meta name="twitter:title" content="Inventory of clinical studies in renal MRI">
  <meta name="twitter:description" content="An inventory of clinical studies involving renal MRI, either ongoing or closed.">
  <meta name="twitter:url" content="http://localhost:4000/resources/inventory%20of%20clinical%20studies%20in%20renal%20mri/">

  
    <meta name="twitter:card" content="summary">
    
      <meta name="twitter:image" content="http://localhost:4000/assets/images/bio-photo.jpg">
    
  

  



  <meta property="article:published_time" content="2022-11-19T19:54:09+02:00">





  

  


<link rel="canonical" href="http://localhost:4000/resources/inventory%20of%20clinical%20studies%20in%20renal%20mri/">




<script type="application/ld+json">
  {
    "@context": "https://schema.org",
    
      "@type": "Person",
      "name": "Your Name",
      "url": "http://localhost:4000/",
      "sameAs": ["https://twitter.com/","https://github.com/"]
    
  }
</script>







<!-- end _includes/seo.html -->



  <link href="/feed.xml" type="application/atom+xml" rel="alternate" title="Minimal Mistakes Feed">


<!-- https://t.co/dKP3o1e -->
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<script>
  document.documentElement.className = document.documentElement.className.replace(/\bno-js\b/g, '') + ' js ';
</script>

<!-- For all browsers -->
<link rel="stylesheet" href="/assets/css/main.css">
<link rel="preload" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@5/css/all.min.css" as="style" onload="this.onload=null;this.rel='stylesheet'">
<noscript><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@5/css/all.min.css"></noscript>



    <!-- start custom head snippets -->

<!-- insert favicons. use https://realfavicongenerator.net/ -->

<!-- end custom head snippets -->

  </head>

  <body class="layout--splash">
    <nav class="skip-links">
  <ul>
    <li><a href="#site-nav" class="screen-reader-shortcut">Skip to primary navigation</a></li>
    <li><a href="#main" class="screen-reader-shortcut">Skip to content</a></li>
    <li><a href="#footer" class="screen-reader-shortcut">Skip to footer</a></li>
  </ul>
</nav>

    <!--[if lt IE 9]>
<div class="notice--danger align-center" style="margin: 0;">You are using an <strong>outdated</strong> browser. Please <a href="https://browsehappy.com/">upgrade your browser</a> to improve your experience.</div>
<![endif]-->

    

<div class="masthead">
  <div class="masthead__inner-wrap">
    <div class="masthead__menu">
      <nav id="site-nav" class="greedy-nav">
        
          <a class="site-logo" href="/"><img src="/assets/images/logo_parenchima.png" alt="Custom Title"></a>
        
        <a class="site-title" href="/">
          Custom Title
          <span class="site-subtitle">Development Test Site</span>
        </a>
        <ul class="visible-links"><li class="masthead__menu-item">
              <a href="/community/">Community</a>
            </li><li class="masthead__menu-item">
              <a href="/participants/">Participants</a>
            </li><li class="masthead__menu-item">
              <a href="/resources/">Resources</a>
            </li><li class="masthead__menu-item">
              <a href="/about/">About</a>
            </li></ul>
        
        <button class="search__toggle" type="button">
          <span class="visually-hidden">Toggle search</span>
          <i class="fas fa-search"></i>
        </button>
        
        <button class="greedy-nav__toggle hidden" type="button">
          <span class="visually-hidden">Toggle menu</span>
          <div class="navicon"></div>
        </button>
        <ul class="hidden-links hidden"></ul>
      </nav>
    </div>
  </div>
</div>


    <div class="initial-content">
      

<div id="main" role="main">
  <article class="splash" itemscope itemtype="https://schema.org/CreativeWork">
    <meta itemprop="headline" content="Inventory of clinical studies in renal MRI">
    <meta itemprop="description" content="An inventory of clinical studies involving renal MRI, either ongoing or closed.">
    <meta itemprop="datePublished" content="2022-11-19T19:54:09+02:00">
    

    <section class="page__content" itemprop="text">
      <h2 id="inventory-of-clinical-studies-in-renal-mri">Inventory of clinical studies in renal MRI</h2>

<p>This inventory provides a list of ongoing or completed clinical studies involving MRI of the kidney. The list was compiled by PARENCHIMA working group 3 and continues to be maintained. Initial data were collected from working group members and through individual contact with external researchers. The inventory is dynamic and will continue to be updated and maintained as new studies are started, or ongoing studies are closed.</p>

<blockquote>
  <p>The inventory is currently being revised to include the most up to date information. For ongoing studies, investigators are asked to provide a clinical trial registration number and/or a link to a published study protocol. For studies that are not yet recruiting, a link to the award is sufficient. For completed studies, investigators will be asked to provide a link to a publication reporting on the primary outcome. Studies that are not able to provide these informations will be removed from the inventory.</p>
</blockquote>

<p>For any comments, corrections or additions, please refer to the following contacts:</p>

<p>All application areas except ADPKD and Transplantation: contact the working group 3 lead.
ADPKD studies: contact the ADPKD task force lead.
Renal transplantation studies: contact the Transplantation Task force lead.
Notations used:</p>

<p>P = Prospective, R = Retrospective
O = Observational, I = Interventional</p>

<p><strong>Ongoing multi-centre studies (excluding ADPKD and Transplantation)</strong></p>

<table>
  <thead>
    <tr>
      <th>Study name</th>
      <th>Clinical area</th>
      <th>N. patients</th>
      <th>Study type</th>
      <th>Protocol / registration</th>
      <th>Principal investigator/ Contact person</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>iBEAt</td>
      <td>DKD</td>
      <td>500 T2D, 50 T1D</td>
      <td>P, O</td>
      <td>Protocol paper</td>
      <td>Prof. Steven Sourbron</td>
    </tr>
    <tr>
      <td>HEROIC</td>
      <td>DKD</td>
      <td>500</td>
      <td>P, O</td>
      <td>Protocol paper</td>
      <td>Dr Kieran Mccafferty</td>
    </tr>
    <tr>
      <td>AFiRM</td>
      <td>CKD</td>
      <td>450</td>
      <td>P, O</td>
      <td>Award</td>
      <td>Prof. Nicholas Selby</td>
    </tr>
    <tr>
      <td>EMPA_KIDNEY MRI sub-study</td>
      <td>CKD</td>
      <td>60</td>
      <td>P, I</td>
      <td>Registration</td>
      <td>Prof. Richard Haynes</td>
    </tr>
    <tr>
      <td>DWI for kidney cortical intersitial fibrosis prediction</td>
      <td>Renal transplantation</td>
      <td>250</td>
      <td>P, O</td>
      <td>MISSING</td>
      <td>Prof Jean-Paul Vallee</td>
    </tr>
  </tbody>
</table>

<p><strong>Ongoing single-centre studies (excluding ADPKD and Transplantation)</strong></p>

<table border="0" cellpadding="0" cellspacing="0" class="oc-alternate-rows">
    <thead>
        <tr>
            <th>Study</th>
            <th>Clinical area</th>
            <th>N. patients</th>
            <th>Study type</th>
            <th>Main
                <br />info</th>
            <th>Principal investigator/
                <br />Contact person</th>
        </tr>
    </thead>
    <tbody>
        <tr height="44">
            <td height="44">SUGAR</td>
            <td>Heart failure, Diabetes</td>
            <td>105</td>
            <td>Prospective, Interventional (Empagliflozin)</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://clinicaltrials.gov/ct2/show/NCT03485092">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Naveed.Sattar@glasgow.ac.uk">Prof. Naveed Sattar</a></td>
        </tr>
        <tr height="19">
            <td height="19">AM-01</td>
            <td>DKD</td>
            <td>66</td>
            <td>Prospective, Observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:seema.baid-agrawal@vgregion.se">Dr Seema Baid-Agrawal</a>
                <br /><a href="http://web.archive.org/web/20210620070423/mailto:paul.hockings@antarosmedical.com">Dr Paul Hockings</a></td>
        </tr>
        <tr>
            <td>Advanced MRI for improved diagnosis and prediction of treatment response in Wilms’ tumour patient</td>
            <td>Wilms' tumour</td>
            <td>110</td>
            <td>Prospective, Observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:christopher.clark@ucl.ac.uk">Dr Chris Clark</a></td>
        </tr>
        <tr>
            <td>Renal diffusion in CKD</td>
            <td>CKD</td>
            <td>150</td>
            <td>Prospective, Observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:jean-paul.vallee@hcuge.ch">Dr Jean-Paul Vallée</a></td>
        </tr>
        <tr>
            <td>ReMARK</td>
            <td>Healthy volunteers</td>
            <td>20</td>
            <td>Prospective, Observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:a.deboer-21@umcutrecht.nl">Dr Anneloes de Boer</a></td>
        </tr>
        <tr>
            <td>ReFINED</td>
            <td>CKD, hypertension, healthy volunteers</td>
            <td>10/10/15</td>
            <td>Prospective, Observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:a.deboer-21@umcutrecht.nl">Dr Anneloes de Boer</a></td>
        </tr>
        <tr>
            <td>Role of digital pathology and MRI in the early detection of interstitial fibrosis in CKD</td>
            <td>CKD (both native and transplanted kidneys)</td>
            <td>75</td>
            <td>Prospective, Observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:cnicolau@clinic.cat">Dr Carlos Nicolau</a></td>
        </tr>
        <tr>
            <td>Gender-BOLD</td>
            <td>CKD and controls</td>
            <td>110</td>
            <td>Prospective, Observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:menno.pruijm@chuv.ch">Dr Menno Pruijm</a></td>
        </tr>
        <tr>
            <td>Functional MRI in the diagnostics of diabetic nephropathy in patients with type 2 DM</td>
            <td>DKD</td>
            <td>90</td>
            <td>Prospective, Observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:nikolic.olivera@gmail.com">Dr Olivera Nikolic</a></td>
        </tr>
        <tr height="19">
            <td height="19">ACH471-205
                <br />MRI sub-study</td>
            <td>C3G -
                <br />IC-MPGN rare disease</td>
            <td>7</td>
            <td>Prospective, Interventional (ACH-0144471)</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://clinicaltrials.gov/ct2/show/NCT03723512">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:acaroli@marionegri.it">Dr Anna Caroli</a></td>
        </tr>
        <tr>
            <td>ROCKIES</td>
            <td>Diabetes</td>
            <td>40 (T2D and healthy controls)</td>
            <td>Prospective, Interventional
                <br />(Ertugliflozin)</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://clinicaltrials.gov/ct2/show/NCT04027530">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:d.vanraalte@amsterdamumc.nl">Dr Daniel van Raalte</a></td>
        </tr>
        <tr height="26">
            <td height="26">GCKD MRI sub-study</td>
            <td>CKD</td>
            <td>30</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/http://charite.de/">Prof. Dr. K. U. Eckardt</a> / <a href="http://web.archive.org/web/20210620070423/mailto:maurice.heimer@charite.de">Dr. Maurice Heimer</a></td>
        </tr>
        <tr>
            <td>Improvement of diagnostics of myeloma specific renal changes by functional MRI-biomarkers</td>
            <td>multiple myeloma</td>
            <td>40 patients, 10 healthy volunteers</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Alexandra.Ljimani@med.uni-duesseldorf.de">Dr Alexandra Ljimani</a></td>
        </tr>
        <tr>
            <td>Renal pathologies in rheumatological diseases: Improvement of diagnostics using functional magnetic resonance imaging</td>
            <td>Lupus</td>
            <td>30</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Alexandra.Ljimani@med.uni-duesseldorf.de">Dr Alexandra Ljimani</a></td>
        </tr>
        <tr>
            <td>Quantitative magnetization transfer MRI for evaluation of renal fibrosis</td>
            <td>Renovascular disease</td>
            <td>15</td>
            <td>prospective, observational</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://clinicaltrials.gov/ct2/show/NCT04508049">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:lerman.lilach@mayo.edu">Prof. Lilach O. Lerman</a></td>
        </tr>
        <tr>
            <td>Advanced diffusion imaging for management of renal cancer: oncologic control and renal functional reserve</td>
            <td>Renal cancer</td>
            <td>24 healthy controls, 150 renal mass patients&nbsp;</td>
            <td>prospective, observational</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://urlsand.esvalabs.com/?u=https%3A%2F%2Fprojectreporter.nih.gov%2Fproject_info_description.cfm%3Faid%3D10051642%26icde%3D52231185%26ddparam%3D%26ddvalue%3D%26ddsub%3D%26cr%3D1%26csb%3Ddefault%26cs%3DASC%26pball&amp;e=1265236c&amp;h=693f4396&amp;f=y&amp;p=y">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Eric.Sigmund@nyulangone.org">Dr Eric Sigmund</a>
                <br /><a href="http://web.archive.org/web/20210620070423/mailto:Hersh.Chandarana@nyulangone.org">Dr Hersh Chandarana</a>&nbsp;</td>
        </tr>
        <tr>
            <td>Role of MMP-10 and tissue perfusion in diagnosis and prognosis of renal and cardiovascular disease in patients with 2 type diabetes mellitus</td>
            <td>Diabetes</td>
            <td>70 with MRI (268 in total)</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:nrgarcia@unav.es">Dr Nuria García Fernández</a></td>
        </tr>
        <tr>
            <td>Quantitative susceptible imaging of the human kidney on a clinical MRI system</td>
            <td>Mixed</td>
            <td>20 renal patients, 10 healthy volunteers</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Alexandra.Ljimani@med.uni-duesseldorf.de">Dr Alexandra Ljimani</a></td>
        </tr>
        <tr>
            <td>Evaluation of CT-contrast agent induced ATN by functional renal MR-imaging</td>
            <td>CT-contrast agent induced ATN</td>
            <td>40</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Alexandra.Ljimani@med.uni-duesseldorf.de">Dr Alexandra Ljimani</a></td>
        </tr>
        <tr>
            <td>Evaluation of renal damage after a SARS-CoV-2 infection using functional, contrast-free kidney MRI</td>
            <td>COVID-19</td>
            <td>30</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Alexandra.Ljimani@med.uni-duesseldorf.de">Dr Alexandra Ljimani</a></td>
        </tr>
        <tr>
            <td>MAGNA VICTORIA study
                <br />
            </td>
            <td>T2DM patients and healthy controls
                <br />
            </td>
            <td>150</td>
            <td>prospective, interventional (liraglutide)</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://clinicaltrials.gov/ct2/show/NCT01761318">Protocol1</a>
                <br /><a href="http://web.archive.org/web/20210620070423/https://clinicaltrials.gov/ct2/show/NCT02660047">Protocol2</a>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:I.A.Dekkers@lumc.nl">Dr Ilona Dekkers</a>
                <br /><a href="http://web.archive.org/web/20210620070423/mailto:h.j.lamb@lumc.nl">Prof Dr Hiddo J Lamb</a></td>
        </tr>
        <tr>
            <td>NEO study</td>
            <td>Obesity</td>
            <td>2500</td>
            <td>prospective, observational</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://www.lumc.nl/org/neo-studie/?setlanguage=English&amp;setcountry=en">Link</a>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:I.A.Dekkers@lumc.nl">Dr Ilona Dekkers</a>
                <br /><a href="http://web.archive.org/web/20210620070423/mailto:h.j.lamb@lumc.nl">Prof Dr Hiddo J Lamb</a>
                <br />
            </td>
        </tr>
    </tbody>
</table>

<p><strong>Completed studies (excluding ADPKD and Transplantation)</strong></p>

<table border="0" cellpadding="0" cellspacing="0" class="oc-alternate-rows">
    <thead>
        <tr>
            <th>Study</th>
            <th>Clinical area</th>
            <th>N. patients</th>
            <th>Study type</th>
            <th>Main
                <br />info</th>
            <th>Principal investigator/
                <br />Contact person</th>
        </tr>
    </thead>
    <tbody>
        <tr height="44">
            <td height="44">REMIND-CKD</td>
            <td>CKD</td>
            <td>26</td>
            <td>prospective, observational</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://academic.oup.com/ndt/article/35/6/955/5525254">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Nicholas.Selby@nottingham.ac.uk">Prof. Nicholas Selby</a></td>
        </tr>
        <tr height="19">
            <td height="19">REMIND-AKI</td>
            <td>AKI</td>
            <td>10</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Nicholas.Selby@nottingham.ac.uk">Prof. Nicholas Selby</a></td>
        </tr>
        <tr>
            <td>Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol.</td>
            <td>healthy volunteers (non-diabetic subjects)</td>
            <td>15 normal weight, 15 overweight, 15 obese</td>
            <td>prospective, interventional (Empagliflozin)</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://doi.org/10.1007/s12325-018-0708-y">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:menno.pruijm@chuv.ch">Dr Menno Pruijm</a></td>
        </tr>
        <tr>
            <td>Renal NCE-MRI in Healthy Volunteers</td>
            <td>healthy volunteers</td>
            <td>16</td>
            <td>prospective, observational</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://clinicaltrials.gov/ct2/show/NCT02618460">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:acaroli@marionegri.it">Dr Anna Caroli</a></td>
        </tr>
        <tr>
            <td>Renal DCE-MRI in healthy volunteers comparing two imaging sequences (FLASH/KWIC) and use of iohexol clearance as clinical reference test</td>
            <td>healthy volunteers</td>
            <td>10</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Eli.Bjovad.Eikefjord@hib.no">Dr Eli Eikefjord</a></td>
        </tr>
        <tr>
            <td>Test-retest renal DCE-MRI in healthy volunteers and use of iohexol clearance as clinical reference test</td>
            <td>healthy volunteers</td>
            <td>20</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Eli.Bjovad.Eikefjord@hib.no">Dr Eli Eikefjord</a></td>
        </tr>
        <tr>
            <td>Renal DCE-MRI in living kidney donors</td>
            <td>Kidney donors</td>
            <td>20</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Eli.Bjovad.Eikefjord@hib.no">Dr Eli Eikefjord</a></td>
        </tr>
        <tr>
            <td>Renal pCASL Repeatability/Reproducibility Study</td>
            <td>healthy volunteers</td>
            <td>10</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:mail@dougpendse.com">Dr Doug Pendse</a></td>
        </tr>
        <tr>
            <td>MRI in healthy volunteers</td>
            <td>healthy volunteers</td>
            <td>7</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:i.gordon@ucl.ac.uk">Dr Isky Gordon</a></td>
        </tr>
        <tr height="19">
            <td height="19">MRI reproducibility in healthy volunteers</td>
            <td>healthy volunteers</td>
            <td>16</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:i.gordon@ucl.ac.uk">Dr Isky Gordon</a></td>
        </tr>
        <tr>
            <td>MRI in paediatric CKD</td>
            <td>paediatric CKD</td>
            <td>11</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:i.gordon@ucl.ac.uk">Dr Isky Gordon</a></td>
        </tr>
        <tr>
            <td>Reproducibility of Single Kidney GFR with DCE-MRI in healthy volunteers</td>
            <td>healthy volunteers</td>
            <td>34</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:i.gordon@ucl.ac.uk">Dr Isky Gordon</a></td>
        </tr>
        <tr>
            <td>DWI in healthy volunteers</td>
            <td>healthy volunteers</td>
            <td>10</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:paul.summers@ieo.it">Dr Paul Summers</a></td>
        </tr>
        <tr height="26">
            <td height="26">DCE-MRI in renal pathology</td>
            <td>mixed renal pathology</td>
            <td>30</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:paul.summers@ieo.it">Dr Paul Summers</a></td>
        </tr>
        <tr>
            <td>Renden</td>
            <td>resistant hypertension</td>
            <td>75</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:a.deboer-21@umcutrecht.nl">Dr Anneloes de Boer</a></td>
        </tr>
        <tr>
            <td>EnCORED: renal artery and parenchymal changes after RDN</td>
            <td>therapy resistant hypertension</td>
            <td>96</td>
            <td>prospective, interventional (RDN)</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:a.deboer-21@umcutrecht.nl">Dr Anneloes de Boer</a></td>
        </tr>
        <tr>
            <td>Influence of RAAS inhibition; determine the influence of RAAS inhibition on kidney oxygenation</td>
            <td>CKD, healthy volunteers</td>
            <td>10 CKD patients, 5 healthy volunteers</td>
            <td>prospective, interventional (RAAS inhibitors)</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:a.deboer-21@umcutrecht.nl">Dr Anneloes de Boer</a></td>
        </tr>
        <tr>
            <td>LauBOLD</td>
            <td>CKD, hypertension, healthy volunteers</td>
            <td>224</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:menno.pruijm@chuv.ch">Dr Menno Pruijm</a></td>
        </tr>
        <tr>
            <td>4R01DK093793-05: Longitudinal Changes in the Intra-Renal Oxygenation by BOLD MRI in patients with CKD</td>
            <td>CKD, healthy</td>
            <td>66</td>
            <td>prospective, observational</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://projectreporter.nih.gov/project_info_details.cfm?aid=9096783&amp;icde=50583397">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:PPrasad@northshore.org">Dr Pottumarthi Prasad</a></td>
        </tr>
        <tr>
            <td>5R21DK079080-02: The intra-renal oxygenation in CKD as evaluated by BOLD-MRI</td>
            <td>CKD, healthy</td>
            <td>45</td>
            <td>cross-sectional, observational</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://projectreporter.nih.gov/project_info_details.cfm?aid=7936137&amp;icde=50583457">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:PPrasad@northshore.org">Dr Pottumarthi Prasad</a></td>
        </tr>
        <tr>
            <td>CKD Optimal Management with Binders and Nicotinamide
                <br />(COMBINE)</td>
            <td>CKD</td>
            <td>122</td>
            <td>prospective, interventional (nicotinamide and lanthanum carbonate)</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://cjasn.asnjournals.org/content/15/6/776.long">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:anand.srivastava@northwestern.edu" target="_blank">Dr Anand Srivastava</a></td>
        </tr>
        <tr>
            <td>Role of MMP-10 and tissue perfusion in nephropathy associated to type 2 diabetes mellitus: clinical and experimental study</td>
            <td>Diabetes</td>
            <td>45 controls and 44 T2DM patients with MRI (111 and 268 in total)</td>
            <td>prospective, observational</td>
            <td>Link</td><td>Dr Nuria García Fernández</td>
        </tr>
    </tbody>
</table>

<p><strong>Ongoing studies in ADPKD</strong></p>

<table border="0" cellpadding="0" cellspacing="0" class="oc-alternate-rows">
    <thead>
        <tr>
            <th>Study</th>
            <th>Center</th>
            <th>N patients</th>
            <th>Study type</th>
            <th>MR sequences (besides anatomical)</th>
            <th>Main info</th>
            <th>Contact person</th>
        </tr>
    </thead>
    <tbody>
        <tr height="44">
            <td>MR-Progression-Evaluation of Chronic Kidney Disease</td>
            <td height="44">Medical University of Vienna, Austria</td>
            <td>90 early stage ADPKD, 30 healthy controls</td>
            <td>Observational</td>
            <td>T1&amp;T2 mapping, DWI/DTI, MRE</td>
            <td>DRKS-ID: DRKS00015866</td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:wolf.marcos@gmail.com">Dr Marcos Wolf</a></td>
        </tr>
        <tr height="19">
            <td>Functional MRI in ADPKD</td>
            <td height="19">Universitair Ziekenhuis Brussel, Belgium</td>
            <td>30
                <br />
                <br />
            </td>
            <td>Observational</td>
            <td>DCE</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Patricia.VanderNiepen@uzbrussel.be">Dr Patricia van der Niepen</a></td>
        </tr>
        <tr height="19">
            <td>PKD – imaging the genomic derangements with ultra-sensitive metabolic MRI</td>
            <td height="19">Aarhus University Hospital, Denmark</td>
            <td>40</td>
            <td>Interventional</td>
            <td>spsp-SPIRAL, T1&amp;T2 mapping, DWI, BOLD, pCASL</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/http://clin.au.dk/">Dr Christoffer Laustsen</a></td>
        </tr>
        <tr height="26">
            <td>Multiparametric MRI to detect, quantify and predict prognosis of ADPKD</td>
            <td height="26">Haukeland University Hospital/University of Bergen, Norway</td>
            <td>30 ADPKD patients, 12 non-ADPKD subjects</td>
            <td>Observational</td>
            <td>DWI/DTI, BOLD, T1&amp;T2 mapping, ASL</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:Eli.Bjovad.Eikefjord@hib.no">Dr Eli Eikefjord</a></td>
        </tr>
        <tr height="44">
            <td>TOOL</td>
            <td height="44">Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy</td>
            <td>20</td>
            <td>Interventional (Tolvaptan Plus Octreotide LAR Combination)</td>
            <td>DWI, PC-MRI</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://clinicaltrials.gov/ct2/show/NCT03541447">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:acaroli@marionegri.it">Dr Anna Caroli</a></td>
        </tr>
        <tr height="19">
            <td>Renal fibrosis, microRNA and cardiovascular risk in ADPKD: effect of tolvaptan therapy</td>
            <td height="19">Sapienza University, Rome, Italy</td>
            <td>30+30</td>
            <td>Interventional (Tolvaptan)</td>
            <td>DCE</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:silvia.lai@uniroma1.it">Dr Silvia Lai</a></td>
        </tr>
        <tr>
            <td>STAGED-PKD</td>
            <td>77 centers (USA, Japan, Germany/Austria)</td>
            <td>640</td>
            <td>Interventional (venglustat)</td>
            <td>
                <br />
            </td>
            <td>EudraCT number: 2017-004084-12
                <br /><a href="http://web.archive.org/web/20210620070423/https://clinicaltrials.gov/ct2/show/NCT03523728">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/http://sanofi.com/">Sanofi</a></td>
        </tr>
        <tr height="19">
            <td>Imaging to define disease progression in ADPKD</td>
            <td height="19">University of Sheffield and Sheffield Kidney Institute, Sheffield, UK</td>
            <td>35</td>
            <td>prospective, observational</td>
            <td>
                <br />
            </td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/http://sheffield.ac.uk/">Dr Rosylin Simms</a></td>
        </tr>
    </tbody>
</table>

<p><strong>Completed studies in ADPKD</strong></p>

<table border="0" cellpadding="0" cellspacing="0" class="oc-alternate-rows">
    <thead>
        <tr>
            <th>Study</th>
            <th>Center</th>
            <th>N. patients</th>
            <th>Study type</th>
            <th>MR sequences (besides anatomical)</th>
            <th>Main
                <br />info</th>
            <th>Contact person</th>
        </tr>
    </thead>
    <tbody>
        <tr height="44">
            <td height="44">EUROCYST</td>
            <td>13 centers around Europe
                <br />(DWI substudy: Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy)</td>
            <td>~ 600
                <br />(DWI subgroup - 15)</td>
            <td>prospective, observational</td>
            <td>anatomical (all patients),
                <br />DWI (subgroup)</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://clinicaltrials.gov/ct2/show/NCT02187432">Link</a></td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:acaroli@marionegri.it">Dr Anna Caroli</a> (DWI subgroup)</td>
        </tr>
        <tr height="19">
            <td height="19">Functional kidney MRI to identify novel biomarkers of disease progression in ADPKD</td>
            <td>University of Sheffield and Sheffield Kidney Institute, Sheffield, UK</td>
            <td>29</td>
            <td>prospective, observational</td>
            <td>T2*, DWI, DTI, PC-MRI</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/http://sheffield.ac.uk/">Dr Rosylin Simms</a></td>
        </tr>
        <tr>
            <td>Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease
                <br />
                <br />
            </td>
            <td>Sapienza, University of Rome, UOC Nephrology,
                <br />Policlinico Umberto I Hospital</td>
            <td>27</td>
            <td>prospective, observational</td>
            <td>DCE-MRI</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:silvia.lai@uniroma1.it">Dr Silvia Lai</a></td>
        </tr>
        <tr>
            <td>Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.</td>
            <td>Sapienza, University of Rome, UOC Nephrology,
                <br />Policlinico Umberto I Hospital</td>
            <td>15</td>
            <td>prospective, observational</td>
            <td>DCE-MRI</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:silvia.lai@uniroma1.it">Dr Silvia Lai</a></td>
        </tr>
    </tbody>
</table>

<p><strong>Ongoing studies in Transplantation</strong></p>

<table class="oc-alternate-rows">
    <tbody>
        <tr>
            <td><strong>Study</strong></td>
            <td><strong>Center</strong></td>
            <td><strong>N. Patients</strong></td>
            <td><strong>Study type</strong></td>
            <td><strong>MR sequences (besides anatomical)</strong></td>
            <td><strong>Main info</strong></td>
            <td><strong>Contact person</strong></td>
        </tr>
        <tr>
            <td>
                <div data-empty="true">Risk factor evaluation for inferior outcome after kidney transplantation by assessment of renal pathophysiology with functional MRI in correlation with molecular markers</div>
            </td>
            <td>
                <div data-empty="true">Hannover Medical School, Germany</div>
            </td>
            <td>
                <div data-empty="true">26</div>
            </td>
            <td>
                <div data-empty="true">observational</div>
            </td>
            <td>
                <div data-empty="true">T2 TSE, T1, ASL, DWI, DTI, T1-Map</div>
            </td>
            <td>
                <div data-empty="true">
                    <br />
                </div>
            </td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/mailto:derlin.katja@mh-hannover.de">Dr Katja Derlin</a></div>
            </td>
        </tr>
        <tr>
            <td>
                <div data-empty="true">Artificial intelligence-based analysis of MRI biomarkers to detect allograft dysfunction after kidney transplantation</div>
            </td>
            <td>
                <div data-empty="true">Hannover Medical School, Germany</div>
            </td>
            <td>
                <div data-empty="true">200</div>
            </td>
            <td>
                <div data-empty="true">observational</div>
            </td>
            <td>
                <div data-empty="true">T2 TSE, T1, ASL, DWI, DTI, T1-Map, BOLD</div>
            </td>
            <td>
                <div data-empty="true">
                    <br />
                </div>
            </td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/mailto:derlin.katja@mh-hannover.de">Dr Katja Derlin</a></div>
            </td>
        </tr>
        <tr>
            <td>
                <div data-empty="true">Longitudinal evaluation of renal allograft function after transplantation using ASL and IVIM</div>
            </td>
            <td>
                <div data-empty="true">Clínica Universidad de Navarra, Spain</div>
            </td>
            <td>
                <div data-empty="true">40 transplanted patients, 20 controls (eGFR&gt;60)&nbsp;</div>
            </td>
            <td>
                <div data-empty="true">observational</div>
            </td>
            <td>
                <div data-empty="true">T1 VIBE, T2 HASTE, ASL, IVIM
                    <br />
                    <br />
                </div>
            </td>
            <td>
                <div data-empty="true">
                    <br />
                </div>
            </td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/mailto:mfseara@unav.es">Prof Maria Fernandez Seara</a></div>
            </td>
        </tr>
        <tr>
            <td>TransRASL</td>
            <td>
                <div data-empty="true">University of Glasgow, UK</div>
            </td>
            <td>
                <div data-empty="true">20</div>
            </td>
            <td>
                <div data-empty="true">observational</div>
            </td>
            <td>
                <div data-empty="true">T1 Map, ASL, T2*, DWI, DTI</div>
            </td>
            <td>
                <div data-empty="true">
                    <br />
                </div>
            </td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/http://glasgow.ac.uk/">Dr Paddy Mark</a></div>
            </td>
        </tr>
        <tr>
            <td>diffusion MRI for kidney cortical intersitial fibrosis prediction</td>
            <td>University of Geneve, Switzerland</td>
            <td>246 (both native and transplant)</td>
            <td>observational</td>
            <td>RESOLVE (DWI), T1, T2</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/http://unige.ch/">Dr Jean-Paul Vallee</a></td>
        </tr>
        <tr>
            <td>ACRADYS</td>
            <td>University Medical Center Utrecht, the Netherlands</td>
            <td>50</td>
            <td>observational</td>
            <td>BOLD, ASL, DTI</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/http://umcutrecht.nl/">Dr Anneloes de Boer</a></td>
        </tr>
        <tr>
            <td>Multicentric Study of diffusion MRI for kidney cortical intersitial fibrosis prediction</td>
            <td>University of Geneve. University of Lausanne, Fribourg Hospital; Switzerland</td>
            <td>250</td>
            <td>observational</td>
            <td>RESOLVE (DWI), T1, T2</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/http://unige.ch/">Dr Jean-Paul Vallee</a>, <a href="http://web.archive.org/web/20210620070423/mailto:menno.pruijm@chuv.ch">Dr Menno Pruijm</a>, <a href="http://web.archive.org/web/20210620070423/mailto:Harriet.Thoeny@h-fr.ch">Prof Harriet Thoeny</a></td>
        </tr>
        <tr>
            <td>Artificial intelligence-based analysis of MRI biomarkers to detect allograft dysfunction after kidney transplantation</td>
            <td>
                <div data-empty="true">Hannover Medical School, Germany; University Medical Center Groeningen, the Netherlands</div>
            </td>
            <td>
                <div data-empty="true">200 renal transplant patients, 50 living donors</div>
            </td>
            <td>
                <div data-empty="true">observational</div>
            </td>
            <td>ASL, DWI, IVIM, DTI, T1/T2 mapping, BOLD</td>
            <td>
                <div data-empty="true">
                    <br />
                </div>
            </td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/mailto:c.moers@umcg.nl">Dr Cyril Moers</a>,&nbsp;</div>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/mailto:derlin.katja@mh-hannover.de">Dr Katja Derlin</a></div>
            </td>
        </tr>
        <tr>
            <td>Noninvasive Evaluation of Renal Allograft Fibrosis by MRI</td>
            <td>Kidney transplant recipients</td>
            <td>20</td>
            <td>prospective, observational</td>
            <td>MT, B1, B0, T1 mapping, DWI, BOLD, and ASL</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:lerman.lilach@mayo.edu">Prof. Lilach O. Lerman</a></td>
        </tr>
    </tbody>
</table>

<p><strong>Completed studies in Transplantation</strong></p>

<table border="0" cellpadding="0" cellspacing="0" class="oc-alternate-rows">
    <thead>
        <tr>
            <th>Study</th>
            <th>Center</th>
            <th>N. patients</th>
            <th>Study type</th>
            <th>MR sequences (besides anatomical)</th>
            <th>Main
                <br />info</th>
            <th>Contact person</th>
        </tr>
    </thead>
    <tbody>
        <tr height="44">
            <td height="44">Donor transplant assessment</td>
            <td>Institute of Child Health, London, UK</td>
            <td>8</td>
            <td>prospective, observational</td>
            <td>ASL, BOLD, DWI, T1</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/http://ucl.ac.uk/">Dr Isky Gordon</a></td>
        </tr>
        <tr height="19">
            <td height="19">Longitudinal study of children following renal replacement therapy</td>
            <td>Institute of Child Health, London, UK</td>
            <td>20</td>
            <td>prospective, observational</td>
            <td>ASL, BOLD, DWI, T1</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/http://ucl.ac.uk/">Dr Isky Gordon</a></td>
        </tr>
        <tr>
            <td>Observational study in renal transplants</td>
            <td>University of Glasgow, UK</td>
            <td>20</td>
            <td>prospective, observational</td>
            <td>ASL, T1, DTI, BOLD</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/http://glasgow.ac.uk/">Dr Paddy Mark</a></td>
        </tr>
        <tr>
            <td>Biexponential analysis of DWI: comparison of three different calculation methods in transplanted kidneys</td>
            <td>Uniklinik Duesseldorf Germany</td>
            <td>15</td>
            <td>prospective, observational</td>
            <td>DWI</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://pubmed.ncbi.nlm.nih.gov/23858509/">Link</a></td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/http://med.uni-duesseldorf.de/">Dr. Alexandra Ljimani</a></div>
            </td>
        </tr>
        <tr>
            <td>Correlation of biexponential diffusion parameters with ASL perfusion MRI: results in transplanted kidneys</td>
            <td>Uniklinik Duesseldorf Germany</td>
            <td>17</td>
            <td>prospective, observational</td>
            <td>DWI, ASL</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://pubmed.ncbi.nlm.nih.gov/23249648/">Link</a></td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/http://med.uni-duesseldorf.de/">Dr. Alexandra Ljimani</a></div>
            </td>
        </tr>
        <tr>
            <td>Kidney transplant: functional assessment with DTI at 3T</td>
            <td>Uniklinik Duesseldorf Germany</td>
            <td>40</td>
            <td>prospective, observational</td>
            <td>DTI</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://pubs.rsna.org/doi/full/10.1148/radiol.12112522">Link</a></td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/http://med.uni-duesseldorf.de/">Dr. Alexandra Ljimani</a></div>
            </td>
        </tr>
        <tr>
            <td>Diffusion-attenuated MRI signal of renal allografts: comparison of two different statistical models</td>
            <td>Uniklinik Duesseldorf Germany</td>
            <td>23</td>
            <td>prospective, observational</td>
            <td>DWI/DTI</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://pubmed.ncbi.nlm.nih.gov/21606257/">Link</a></td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/http://med.uni-duesseldorf.de/">Dr. Alexandra Ljimani</a></div>
            </td>
        </tr>
        <tr>
            <td>T2' Imaging of Native Kidneys and Renal Allografts - a Feasibility Study</td>
            <td>Uniklinik Duesseldorf Germany</td>
            <td>24</td>
            <td>prospective, observational</td>
            <td>T2 mapping</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://pubmed.ncbi.nlm.nih.gov/20725876/">Link</a></td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/http://med.uni-duesseldorf.de/">Dr. Alexandra Ljimani</a></div>
            </td>
        </tr>
        <tr>
            <td>Quantification of renal allograft perfusion using arterial spin labeling MRI: initial results</td>
            <td>Uniklinik Duesseldorf Germany</td>
            <td>20</td>
            <td>prospective, observational</td>
            <td>T2 mapping, ASL</td>
            <td><a href="http://web.archive.org/web/20210620070423/https://pubmed.ncbi.nlm.nih.gov/19949799/">Link</a></td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/http://med.uni-duesseldorf.de/">Dr. Alexandra Ljimani</a></div>
            </td>
        </tr>
        <tr height="19">
            <td height="19">Functional MRI of transplanted kidneys using diffusion-weighted imaging</td>
            <td>Uniklinik Duesseldorf Germany</td>
            <td>41</td>
            <td>prospective, observational</td>
            <td>DWI</td>
            <td>
                <br />
            </td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/http://med.uni-duesseldorf.de/">Dr. Alexandra Ljimani</a></div>
            </td>
        </tr>
        <tr>
            <td>Functional multiparametric MRI in delayed graft function after kidney Transplantation</td>
            <td>Hannover Medical School</td>
            <td>70</td>
            <td>prospective, observational</td>
            <td>ASL, DWI, DTI, T2 mapping</td>
            <td>
                <br />
            </td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/mailto:derlin.katja@mh-hannover.de">Dr Katja Derlin</a></div>
            </td>
        </tr>
        <tr>
            <td>Integrated Probabilistic and Computational Framework for Analyzing 3D/4D Medical Images</td>
            <td>Mansoura University, Egypt</td>
            <td>60</td>
            <td>prospective, observational</td>
            <td>m-dixon, DWI, DTI, BOLD</td>
            <td>
                <br />
            </td>
            <td><a href="http://web.archive.org/web/20210620070423/mailto:maboelghar@yahoo.com">Dr Mohamed Abou El-Ghar</a></td>
        </tr>
        <tr>
            <td>
                <div data-empty="true">Metabolic MRI in transplanted kidney</div>
            </td>
            <td>Uniklinik Duesseldorf, Germany</td>
            <td>40</td>
            <td>prospective, observational</td>
            <td>
                <div data-empty="true">T2-HASTE, CEST</div>
            </td>
            <td>
                <br />
            </td>
            <td>
                <div data-empty="true"><a href="http://web.archive.org/web/20210620070423/http://med.uni-duesseldorf.de/">Dr. Alexandra Ljimani</a></div>
            </td>
        </tr>
    </tbody>
</table>


    </section>
  </article>
</div>

    </div>

    
      <div class="search-content">
        <div class="search-content__inner-wrap"><form class="search-content__form" onkeydown="return event.key != 'Enter';">
    <label class="sr-only" for="search">
      Enter your search term...
    </label>
    <input type="search" id="search" class="search-input" tabindex="-1" placeholder="Enter your search term..." />
  </form>
  <div id="results" class="results"></div></div>

      </div>
    

    <div id="footer" class="page__footer">
      <footer>
        <!-- start custom footer snippets -->

<!-- end custom footer snippets -->
        <div class="page__footer-follow">
  <ul class="social-icons">
    
      <li><strong>Follow:</strong></li>
    

    
      
        
          <li><a href="https://twitter.com/renalMRI" rel="nofollow noopener noreferrer"><i class="fab fa-fw fa-twitter-square" aria-hidden="true"></i> Twitter</a></li>
        
      
        
          <li><a href="https://www.researchgate.net/project/PARENCHIMA-Magnetic-Resonance-Imaging-Biomarkers-for-Chronic-Kidney-Disease" rel="nofollow noopener noreferrer"><i class="fab fa-brands fa-researchgate" aria-hidden="true"></i> ResearchGate</a></li>
        
      
        
          <li><a href="/" rel="nofollow noopener noreferrer"><i class="fas fa-link" aria-hidden="true"></i> PARENCHIMA chair: Steven Sourbron</a></li>
        
      
        
          <li><a href="/" rel="nofollow noopener noreferrer"><i class="fas fa-link" aria-hidden="true"></i> PARENCHIMA dissemination lead: Marcos Wolf</a></li>
        
      
    

    
      <li><a href="/feed.xml"><i class="fas fa-fw fa-rss-square" aria-hidden="true"></i> Feed</a></li>
    
  </ul>
</div>

<div class="page__footer-copyright">&copy; 2022 Your Name. Powered by <a href="https://jekyllrb.com" rel="nofollow">Jekyll</a> &amp; <a href="https://mademistakes.com/work/minimal-mistakes-jekyll-theme/" rel="nofollow">Minimal Mistakes</a>.</div>

      </footer>
    </div>

    
  <script src="/assets/js/main.min.js"></script>




<script src="/assets/js/lunr/lunr.min.js"></script>
<script src="/assets/js/lunr/lunr-store.js"></script>
<script src="/assets/js/lunr/lunr-en.js"></script>







  </body>
</html>
